Veterinary Medicine Information website

Nobivac Lepto, süstesuspensioon koertele

Not authorised
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Download as PDF

Product identification

Medicine name:
Nobivac Lepto, süstesuspensioon koertele
Active substance:
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
    1500.00
    antigen unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
    1900.00
    antigen unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Nederland B.V.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1137
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 27/01/2022
Download